
FDA HOMEPAGE
FDA OFFICE HUMAN RESEARCH TRIALS
FDA CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH)
FDA CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)
APPLICATION PROCESS
GOOD CLINICAL PRACTICES (GCP)
FDA OFFICE OF REGULATORY AFFAIRS
FDA DEBARMENT LISTS
FDA FORMS
FDA INFORMATION ESSENTIAL FOR CLINICAL TRIALS
SMALL BUSINESS GUIDE TO FDA
FDA Information Sheets
FDA Contacts for Clinical Trials
FDA Regulations and Information Regarding Protection of Human Research Subjects
FDA Form 1572: What Do the Nine Commitments That Investigators Affirms Mean? (via Children's Hospital in Philadelphia)
Clinical Trials and Human Subject Protection
Good Clinical Practices (GCP) in FDA-Regulated Clinical Trials
FDA List of Disqualified / Restricted Clinical Investigators (PIs must verify that no project staff are on this list)
Federal Regulations for Clinical Investigators
FDA Requirements For Investigators Who Are Also Considered Sponsors of New Drugs (via U. KY)
FDA Requirements For Investigators Who Are Also Considered Sponsors of New Devices (via U. KY)
FDA Forms Download Page
Clinical Investigator Forms (e.g., FDA1571 and FDA1572)
FDA News
FDA Regulatory Guidance & Enforcement Information (via CDER)
FDA Freedom of Information Page
FDA Warning Letters
By Subject [Try "C" for Clinical Investigator, or "I" for Institutional Review Board]
What is a Serious Adverse Event?
MedWatch
MedWatch Form for Voluntary Reporting (Form 3500)
Instructions for Completing MedWatch Form
MedWatch Form 3500 Online
Compliance Oversight
Educational Materials
Guidances and Information Sheets on Human Subject Protection and Good Clinical Practice
Important FDA Contacts for IRBs and Clinical Investigators
Proposed Regulations and Draft Guidances on Human Subject Protection and Good Clinical Practice
Regulations Relating to Human Subject Protection and Good Clinical Practice
Reporting Complaints Related to Human Subject Protection/Good Clinical Practice in FDA-Regulated Clinical Trials
CBER Guidance / Guidelines / Points to Consider
Information on Submitting an Investigational New Drug Application (IND) For a Biological Product
Publications
Guidance Documents
Approved Drug Products (The "Orange Book")
Compliance Activities (Includes Warning Letters to Pharmaceutical Companies)
FDA Information Sheets: Guidance for Clinical Investigators and IRBs
Information for Clinical Investigators
Clinical Investigator Forms (e.g., FDA1571 and FDA1572)
Good Clinical Practices (GCP)
Good Clinical Practice in FDA-Regulated Clinical Trials
Good Clinical Practices (GCP)
Good Clinical Practice (GCP) Consolidated Guidelines from International Conference on Harmonisation (ICH)
FDA Guidance On International Conference on Harmonization (ICH) GCP Guidelines (via US FDA)
Clinical Monitoring -- GCP Q&A (Applied Clinical Trials - July, 2003)
Drug Approval Application Process
Investigational New Drug (IND) Application Process
New Drug Application (NDA) Process
Guidance Documents for Drug Applications
Drug Development and Review Definitions
FAQ on Drug Development and the IND Application Process
FDA Oncology Tools
FDA Policies & Publications Related to Cancer
Regulatory Guidance
Adverse Event Reporting System
INVESTIGATIONAL DRUGS
"Off-Label" and Investigational Use of Marketed Drugs, etc. (via FDA)
Emergency Use of Investigational Drugs or Biologics (via FDA)
From Test Tube to Patient: New Drug Development in the U.S. (via FDA)
The New Drug Development Process
The IND Review Process
The NDA Review Process
FDA - Submission of an IND to the Office of Generic Drugs
Investigational New Drug (IND) Application ProcessInformation from the FDA
Interactive Flow-Chart Describing IND Review Process
FDA - IND Process and Review Procedures
Compliance References: Bioresearch Monitoring
Frequently Requested ORA Documents
Compliance Warning Letters to Investigators, etc.
Investigations Operations Manual
FAQ: Humanitarian Device Exemption Regulations
CDRH Databases
CDRH Guidance Documents Index
CDRH IRB Information Sheets
CDRH Regulatory Manuals
Recent Medical Device Approvals
Significant Risk and Non-Significant Risk Medical Device Studies
Device Advice (Site Index)
Device Advice (Getting Started)
Is My Product Regulated by FDA CDRH?
Premarket Notification [510(k)]
How to Locate 510(k) Guidance Documents
Medical Device Exemptions [510(k) and GMP Requirements]
Getting to Market with a Medical Device
FDA Device Product Code Database
FDA List of Disqualified / Restricted Clinical Investigators (PIs must verify that no project staff are on this list)
Firms and Persons Debarred Under Federal Food, Drug and Cosmetic Act
DHHS PSC Forms Download Site for FDA Forms
FDA Forms Page [
PDF Versions] [
Word Versions]
CBER Forms
CDER Forms
CDRH Forms